INDICATION

Aptensio XR® (methylphenidate HCl extended-release) is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years of age and older.


Limitations of Use
Aptensio XR is not for use in children under 6 years of age because the safety and effectiveness have not been established.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs. Keep Aptensio XR in a safe place to protect it from theft. Never give your methylphenidate to anyone else, because it may cause death or harm to them. Selling or giving away Aptensio XR may harm others and is against the law. Tell your healthcare provider if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs.

What is ADHD?

ADHD is a common medical condition that affects about 10% of children in the United States. Children with ADHD may have behavioral issues that they cannot control, such as trouble sitting still, finishing tasks, or paying attention.

THERE ARE 3 MAIN TYPES (PRESENTATIONS) OF ADHD
1
Predominantly hyperactive-impulsive
2
Predominantly inattentive
3
Combined hyperactive-impulsive and inattentive

ADHD in Children

6.1 million children in the US have been diagnosed with ADHD.

ADHD is approximately twice as common in boys than in girls. In general, boys with ADHD are more likely to be hyperactive and girls are more likely to be inattentive.

ADHD is often inherited within families. For example, adults who have ADHD are more likely to have children who experience similar symptoms.

If you have concerns about how ADHD may affect your family, talk to your child's doctor.

IMPORTANT SAFETY INFORMATION

Aptensio XR is a federally controlled substance (CII) because it contains methylphenidate that can be a target for people who abuse prescription medicines or street drugs.